Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibitors”

205 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 205 results

Early research (Phase 1)UnknownNCT01266720
What this trial is testing

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 6
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666090
What this trial is testing

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University 42
Testing effectiveness (Phase 2)Study completedNCT01210495
What this trial is testing

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Pfizer 224
Early research (Phase 1)Study completedNCT00908869
What this trial is testing

Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm

Who this might be right for
Advanced Neoplasm
Institut Paoli-Calmettes 30
Not applicableStudy completedNCT02923206
What this trial is testing

Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis

Who this might be right for
Preeclampsia
Miltenyi Biomedicine GmbH 21
Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT00842335
What this trial is testing

A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jubilant Innovation Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03954782
What this trial is testing

Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.

Who this might be right for
Telangiectasia, Hereditary HemorrhagicRendu Osler Disease
Hospices Civils de Lyon 61
Early research (Phase 1)Study completedNCT01916447
What this trial is testing

A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.

Who this might be right for
Advanced Gastrointestinal Tumors
Taiho Oncology, Inc. 65
Early research (Phase 1)Study completedNCT00622622
What this trial is testing

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 21
Not applicableUnknownNCT03583242
What this trial is testing

Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 80
Testing effectiveness (Phase 2)Looking for participantsNCT01356290
What this trial is testing

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Who this might be right for
Medulloblastoma RecurrentEpendymoma RecurrentATRT Recurrent+1 more
Medical University of Vienna 232
Not applicableStudy completedNCT02825420
What this trial is testing

Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients

Who this might be right for
Relapsed Ovarian Cancer
PharmaMar 220
Not applicableStudy completedNCT03156868
What this trial is testing

Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer
Spanish Lung Cancer Group 153
Large-scale testing (Phase 3)Ended earlyNCT00574275
What this trial is testing

Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasm
Sanofi 546
Testing effectiveness (Phase 2)UnknownNCT05549466
What this trial is testing

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 84
Not applicableStudy completedNCT02557451
What this trial is testing

Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications

Who this might be right for
Subretinal Haematoma Linked to AMD
Centre Hospitalier Universitaire Dijon 91
Early research (Phase 1)UnknownNCT01266707
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fukushima Medical University 9
Not applicableEnded earlyNCT00657098
What this trial is testing

Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy

Who this might be right for
Metastatic Malignancies
University Medical Center Groningen 73
Load More Results